Answers are grounded in this paper and cite their sources.
For the June 2024 JUOP issue editorial, we bring in associate editor Marisa Clifton from Johns Hopkins Hospital to give our special feature and pictorial series on a recent milestone in our specialty. Dr Patrick Walsh’s 50th anniversary at the Brady Urological Institute marks a milestone not only in his illustrious career but also in the field of urology. Dr Walsh’s contributions to the field of urology, particularly his groundbreaking work in the surgical treatment of prostate cancer, have left an indelible mark. His colleagues, trainees, research collaborators, and mentees recently gathered to celebrate his half-century of dedicated service and remarkable achievements. At the end of the scientific session, Dr Walsh provided a summary of his journey with a 50-minute talk covering 50 years, “If you don't know where you are going, how will you ever get there?” https://youtu.be/2lCx5VpmKJk. Dr Walsh began his career with a deep-seated passion for understanding and treating urological diseases. After completing his medical education and training, he joined the Brady Urological Institute where he embarked on a journey that would transform the landscape of urology. His research has been pivotal in advancing our understanding of prostate cancer, benign prostatic hyperplasia, and other urological conditions. One of Dr Walsh’s most notable research accomplishments is his work on the anatomical basis of continence and potency in men undergoing prostate surgery. His studies on the intricate anatomy of the prostate and surrounding structures laid the groundwork for his later surgical innovations. Before this discovery, prostate cancer surgery often resulted in significant side effects, including excessive blood loss, urinary incontinence, and erectile dysfunction. Dr Walsh’s meticulous research into the anatomical pathways of the nerves responsible for these functions led to a revolutionary surgical technique. This technique has dramatically improved the quality of life for countless men undergoing prostate cancer surgery and is the standard for surgical prostate cancer treatment worldwide. One of the most memorable stories Dr Walsh shared during the weekend celebration was when he met Professor Pieter Donker, a neurourologist, Professor, and Chairman of Urology at the University of Leiden. The evening before Dr Walsh’s first American Association of Genitourinary Surgeons meeting, he and his wife went to a at a restaurant downtown. There he saw an older man standing alone behind the maître, and for the first time in his life invited a total stranger to dine with them—it was Pieter Donker. After a lovely evening in 1977, Dr Walsh thought that was the end of it. However, 4 years later and 4000 miles away, Dr Walsh met Professor Donker for the second time while in Leiden. Donker invited him to visit the windmill museum, but Walsh was interested in what he was doing now that he was retired, and they went instead to Professor Donker’s laboratory. While using his dissecting microscope they identified the branches of the nerves responsible for erection (Figure 1: Things: Dr Walsh’s primitive diagram of the autonomic nerves on 2-13-18, the day they were discovered).Figure 1.: Things: diagram of the anatomy of autonomic nerves in pelvis.Dr Walsh had an incredible impact on the Department of Urology at Johns Hopkins. At the age of 36 years, Dr Walsh became the third urologist in Chief and Director of the Brady Urological Institute, a position he held for 30 years. After assuming the position, he recruited Dr Donald Coffey as the director of the Brady Research Laboratories, recruited many faculty, created the division of Pediatric urology, and relocated the department to the Marburg building to accommodate the increasing need for space to care for patients with urologic conditions. Fortunately, Dr Walsh’s wife Peg was a commercial interior designer who specialized in health care facilities and was able to ensure innovation and function with an integration of elegance that makes the Marburg Building truly unique (Figure 2).Figure 2.: Places: (A) the Historic Marburg Building, (B) the Marburg Library, (C) the Marburg Conference room.Throughout his career, Dr Walsh has been a dedicated mentor to numerous trainees, fellows, and researchers. His commitment to education and mentorship has helped shape the careers of many leading urologists today. The recent celebration of his 50-year tenure at the Brady Urological Institute was a testament to his impact, with many of his former trainees and colleagues in attendance to honor his legacy (Figure 3).Figure 3.: People: Dr Walsh with the current Johns Hopkins Urology Residents at his 50th Celebration.Dr Walsh’s influence extends beyond the operating room and research laboratory. He has been an advocate for patient education and has worked tirelessly to raise awareness about prostate cancer and the importance of early detection and treatment. He recently published his fifth Edition of “Dr. Patrick Walsh's Guide to Surviving Prostate Cancer.” Dr Walsh’s career serves as an inspiration to current and future generations of urologists, reminding us of the profound impact that one dedicated individual can have on the lives of patients and the advancement of medical science. Here is to celebrating Dr Walsh’s remarkable journey and looking forward to the continued influence of his work in the years to come! JUNE 2024 JUOP NEW ARTICLES For June 2024, we have 5 new articles published. In terms of methodologies, they are categorized as clinical trial related (n = 2), health services research (n = 1), retrospective study (n = 1), and rare conditions (n = 1). In addition, we have a healthy dialogue of editorials and replies as authored by Drs Fernando Kim, reza Ghavamian, Akshay Sood, Isamu Tachibana, Jeremy Kurnot, and Kurt Schwieters (student doctor). CLINICAL TRIALS RELATED In a prospective comparative study, Sato et al1 measured lumbar spine bone loss in men on androgen deprivation therapy (ADT) compared with controls (nonrandomized but propensity weighted adjusted) treated with prostatectomy without ADT. Bone loss was measured with quantitative computed tomography (QCT) at baseline and 1 year of treatment. This measurement method was a point of emphasis for the study and had the purpose of trying to eliminate challenges with degenerative disease in the bone that may affect standard dual-energy x-ray absorptiometry (DEXA) standard imaging. The second point of emphasis is that men on ADT will often have CT-based staging where this method of bone mineral density can be added in the same procedure. The ADT had a reduced lumbar bone mineral density reduction of 17.9% vs 8.5% for controls. This drop was greater than previous study with DEXA scans and suggested greater ADT-related bone density changes that previously thought. Reductions in the control group point to possible bone density effects from effects of local disease treatments. Overall, the metrics from these 2 comparative groups should serve as a useful baseline for randomized study. In a prospective study with trial registration at 5 sites in Japan, Kashiwagi et al2 studied the efficacy of percutaneous cryotherapy for tuberous sclerosis related renal angiomyolipoma lesions. The trial was open-label, single-arm, and phase II. They enrolled 15 patients, per their sample size estimates, to include in the efficacy and safety analysis. Overall, they had complete 100% technical success with minimal reductions in renal function (estimated glomerular filtration rate method). Adverse events included hematuria, pain, proteinuria, retroperitoneal hemorrhage, and fever—none grade 3 to 4. This appears to be an attractive treatment option for this rare condition in that the disease is often bilateral, and there is a need for nephron sparing, repeatable treatment. The study also serves as a baseline examination of cryotherapy for such a highly vascular lesion subtype. In terms of our journal’s methodology themed table of contents, this is a noteworthy paper in that it applies a prospective trial based methodology in application to a rare condition. HEALTH SERVICES RESEARCH In a health services research methods study, Mani et al3 used the military TRICARE beneficiary data system to examine PSA screening rates as affected by the COVID-19 pandemic. As expected, there was a decline of 73% in PSA screenings with some rebound later in the pandemic but still less than prepandemic rates. They examine multiple subgroups such as ethnicity and socioeconomic status and discuss comparison with other preventative testing—overall, a nice data analysis to assist any future pandemics that alter resource priorities and avoiding future gaps in preventative care. RETROSPECTIVE STUDY Strup et al4 performed a retrospective study of AUA Census data to examine key trends in telehealth (TH) utilization in the post–COVID-19 era. Overall, TH increased from 11.9% to 81% pre/post pandemic. The data allowed examination of trends by population area, types of TH activities, and age of providers and several other metrics. Barriers were discussed including software, conferencing tools, Internet speed, and reimbursement—overall, a highly useful analysis of census data on an emerging topic. In my clinic, we have certainly pivoted to TH as a primary method for follow-up visits. I still prefer in person new encounters and would be interesting for future study to specifically look at TH strengths and limitations by encounter type. RARE CONDITIONS In a rare condition/case report format, Goradia et al5 detail a routine Xiaflex injection for Peyronie disease that turned complicated with a dorsal penile artery avulsion requiring exploration and ligation. Fortunately, the case turned out well. The authors review the relevant anatomy, side effects of this treatment, and complication management. The case has an oral board examination type format to it and a good review topic in andrology.
No takes yet. Share an insight, caveat, or question.
Clifton et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: